Member Info for Chelsea11

Tbh, Calculus are 4th division when compared to the likes of Redmile. In the wider context, a small beer RNS imo.

…….followed indulgence, of tipple of choice.

Within weekly units, of course 🤪

Https://www.youtube.com/watch?v=jEdTJ8N6u48

Burble - yes to JPM

Our Chief Financial Officer Sath Nirmalananthan will be attending the @J.P Morgan Global Healthcare Conference 2024 taking place in San Francisco, California from 8-11 January.

Wonder if 18th November (appointment date) is significant in respect of clinical data publication.

Commercialisation written all over it.

That way well prove to be correct Ray. However it’s not impossible that there will be a formal, interim update on the SCOPE trial ie. before full cohort results.

Hi Chester.

Yes - the use of the word “majority” in place of a specific number.

I agree Berm. In fact I’ve already lowered my expectations of ORR to a percentage beginning with a 7. Why? Just based on most recent comments from the company having not quoted 85%. This view may not of course be shared by everyone here!

I hadn’t realised until I re-read some stuff that Modi-1 includes melanoma amongst its potential targets. So another shot on that goal in addition to SCIB1/iSCIB1+.

“Potent T cell responses and strong anti-tumour activity have been observed in several cancer models of different tumour types, including melanoma, ovarian, lung, pancreatic and triple negative breast cancer, following administration of the Modi-1 vaccine”

Like everyone else I cannot wait for Q4 SCIB1 data readout but will Modi-1 yet prove to be the company’s most valuable asset. Quite possible.

HAGW.

Isn’t this all just part of the government’s “vision” of dishing out free fat-busting jabs, to get unemployed people off their errrrrr fat backsides and into work?

Next Friday BEFORE the AGM Scinv. In fact it could even be done on a day leading up to Friday. Might not happen of course but the very clear point you miss, is BEFORE the AGM.

Pants down again 😂

As I understand it, statistics show that Australia have the highest rate of melanoma on the planet. The Australasian Melanoma Conference is running on 25th/26th October (link below) and you can see Prof Georgina Long is an opening and closing speaker. Who is she? Well she is one of the Clinical Advisory Panel on the SCOPE trial. Not suggesting there will be any direct link made to Scancell at the conference but what it does illustrate is the high calibre of folks on the Clinical Advisory Panel and Prof Long herself, is well aware of Scancell.

https://www.melanoma2024.com/conference-program

For someone who clearly believes they know everything that’s happening inside the company, you continue to dodge the point that IVS was here nearly a year ago and in addition, there were very clear signs the next acquisition would align to smart manufacturing. You chose not to sell.

PS. As you’re also obviously a last word merchant, bob another post on top of this one and we’re done.

Lots of keyboard clattering there Trotsky.

It was blindingly obvious to me way back that the next acquisition was going to align to smart manufacturing and that’s transparently in my posting history here. Buy and build carries risk of course but I’m prepared to sit and wait having sold a proportion of my holding for profit a while back, to invest elsewhere. That I didn’t sell them all at that time is entirely down to me.

Thanks for answering my question.

The IVS acquisition was announced on 1/11/23 (ie nearly a year ago) and despite your many negative posts of bad fit, niche etc etc you didn’t sell then, nor in the many months that followed. As you yourself admit, you had many opportunities to make a profit and didn’t take them, even though you didn’t agree with the strategic direction of the company. Now you are underwater as a result of your own choices.

Own your investment decisions.

Trotsky - it’s crystal clear to anyone who reads your posts that you don’t believe in both the capability of the senior management team, nor the strategic direction of the company.

With that fact established, why are you invested here? It would be like backing a racehorse that you believe has absolutely no chance of winning, wouldn’t it?

EE - thanks for Crick info. Much appreciated.

Https://x.com/scancellpharma/status/1844660617824669912

On 16 October, Samantha Patson will discuss our novel #CancerVaccine approach, including the latest updates on our SCOPE and MODI studies, in a presentation at the

@festofbiologics

. For more information: https://terrapinn.com/conference/festival-of-biologics/agenda.stm

#Biotech #ImmunoOncology